Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA

Abstract

This study represents the first large-scale analysis of blood-derived ctDNA in HCC in United States. The genomic distinction based on HCC risk factors and the high percentage of potentially actionable genomic alterations suggests potential clinical utility for this technology.